FI91484B - A method for producing a new cell growth regulating factor, oncostatin M. - Google Patents

A method for producing a new cell growth regulating factor, oncostatin M.

Info

Publication number
FI91484B
FI91484B FI865156A FI865156A FI91484B FI 91484 B FI91484 B FI 91484B FI 865156 A FI865156 A FI 865156A FI 865156 A FI865156 A FI 865156A FI 91484 B FI91484 B FI 91484B
Authority
FI
Finland
Prior art keywords
oncostatin
producing
cell growth
new cell
growth regulating
Prior art date
Application number
FI865156A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI865156A (en
FI865156A0 (en
FI91484C (en
Inventor
Joyce M Zarling
Mohammed Shoyab
Hans Marquardt
Marcia B Hanson
Mario N Lioubin
Thomas Joseph Brown
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of FI865156A0 publication Critical patent/FI865156A0/en
Publication of FI865156A publication Critical patent/FI865156A/en
Priority to FI911853A priority Critical patent/FI98373C/en
Publication of FI91484B publication Critical patent/FI91484B/en
Application granted granted Critical
Publication of FI91484C publication Critical patent/FI91484C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
FI865156A 1985-12-20 1986-12-17 Process for Preparing a New Cell Growth Regulating Factor Oncostatin M FI91484C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI911853A FI98373C (en) 1985-12-20 1991-04-17 A novel diagnostically useful polypeptide, oncostatin M

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81123585A 1985-12-20 1985-12-20
US81123585 1985-12-20
US93528386A 1986-11-26 1986-11-26
US93528386 1986-11-26

Publications (4)

Publication Number Publication Date
FI865156A0 FI865156A0 (en) 1986-12-17
FI865156A FI865156A (en) 1987-06-21
FI91484B true FI91484B (en) 1994-03-31
FI91484C FI91484C (en) 1994-07-11

Family

ID=27123452

Family Applications (1)

Application Number Title Priority Date Filing Date
FI865156A FI91484C (en) 1985-12-20 1986-12-17 Process for Preparing a New Cell Growth Regulating Factor Oncostatin M

Country Status (29)

Country Link
JP (1) JP2559035B2 (en)
KR (1) KR920005920B1 (en)
CN (1) CN1017626B (en)
AT (1) AT400444B (en)
AU (2) AU601168B2 (en)
BE (1) BE905957A (en)
CA (1) CA1340296C (en)
CH (1) CH675727A5 (en)
CY (1) CY1608A (en)
DE (2) DE3645095C2 (en)
DK (1) DK174094B1 (en)
ES (1) ES2003180A6 (en)
FI (1) FI91484C (en)
FR (1) FR2597108B1 (en)
GB (1) GB2185485B (en)
GR (1) GR862936B (en)
HK (1) HK65691A (en)
HU (1) HU210694B (en)
IE (1) IE59415B1 (en)
IL (1) IL81017A (en)
IT (1) IT1213428B (en)
LU (1) LU86718A1 (en)
NL (1) NL8603209A (en)
NO (1) NO174556C (en)
NZ (1) NZ218634A (en)
OA (1) OA08494A (en)
PT (1) PT83986B (en)
SE (1) SE505059C2 (en)
SG (1) SG60891G (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
US5681930A (en) * 1985-12-20 1997-10-28 Bristol-Myers Squibb Company Anti-oncostatin M monoclonal antibodies
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
IL97622A (en) * 1990-03-29 1997-06-10 Oncogen Limited Partnership Se Monoclonal antibodies that inhibit growth of kaposi's sarcoma
IL97623A (en) * 1990-03-29 1996-01-19 Bristol Myers Squibb Co Anti-oncostatin m monoclonal antibodies their preparation and pharmaceutical compositions containing them
WO1992002556A1 (en) * 1990-08-02 1992-02-20 Michael Valentine Agrez Human colon cancer cell-derived fibroblast elongation factor
CZ195193A3 (en) * 1992-09-25 1994-04-13 Lilly Co Eli Modified factor-4 of blood platelets, process of its preparation and pharmaceutical preparation in which it is comprised

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits

Also Published As

Publication number Publication date
AU601168B2 (en) 1990-09-06
IL81017A0 (en) 1987-03-31
IT8622787A0 (en) 1986-12-19
SG60891G (en) 1991-08-23
DK615386D0 (en) 1986-12-18
NO174556C (en) 1994-05-25
IE863345L (en) 1987-06-20
DK615386A (en) 1987-06-21
SE8605459L (en) 1987-06-21
AU6776590A (en) 1991-03-14
CY1608A (en) 1992-04-03
IE59415B1 (en) 1994-02-23
CH675727A5 (en) 1990-10-31
DE3643428A1 (en) 1987-09-24
AT400444B (en) 1995-12-27
CA1340296C (en) 1998-12-29
HUT43103A (en) 1987-09-28
DE3645095C2 (en) 1993-11-18
NL8603209A (en) 1987-07-16
FI865156A (en) 1987-06-21
FI865156A0 (en) 1986-12-17
GB2185485B (en) 1990-07-04
PT83986A (en) 1987-01-01
DE3643428C2 (en) 1990-08-23
FR2597108B1 (en) 1991-02-15
NZ218634A (en) 1991-06-25
JPS62236498A (en) 1987-10-16
AU6660886A (en) 1987-06-25
FI91484C (en) 1994-07-11
SE505059C2 (en) 1997-06-16
PT83986B (en) 1989-07-31
KR870005645A (en) 1987-07-06
GB8629997D0 (en) 1987-01-28
NO865178L (en) 1987-06-22
ES2003180A6 (en) 1988-10-16
FR2597108A1 (en) 1987-10-16
SE8605459D0 (en) 1986-12-18
IL81017A (en) 1993-01-14
NO865178D0 (en) 1986-12-19
LU86718A1 (en) 1988-07-14
CN1017626B (en) 1992-07-29
GB2185485A (en) 1987-07-22
CN86108955A (en) 1987-12-02
AU639048B2 (en) 1993-07-15
NO174556B (en) 1994-02-14
GR862936B (en) 1987-10-28
JP2559035B2 (en) 1996-11-27
DK174094B1 (en) 2002-06-10
KR920005920B1 (en) 1992-07-24
ATA340686A (en) 1995-05-15
IT1213428B (en) 1989-12-20
HK65691A (en) 1991-08-23
OA08494A (en) 1988-07-29
BE905957A (en) 1987-06-17
HU210694B (en) 1995-06-28

Similar Documents

Publication Publication Date Title
DE3688916D1 (en) Generation method for limited elements using symmetric axis transformation.
KR900700420A (en) Method for producing 2,3-difluorobenzene
NO163246C (en) PROCEDURE TE FOR POWER PRODUCTION.
IT8121232A0 (en) PROCEDURE FOR PRODUCING L-GLUTAMIC ACID BY FERMENTATION.
ES549713A0 (en) A PROCEDURE FOR PREPARING 1,4-DIHYDROPYRIDINES
ES504732A0 (en) A METHOD FOR PREPARING 2,5-DICETO-D-GLUCONIC ACID
DK379985D0 (en) METHOD FOR PREPARING 6-CHLOR-N-METHYL-2,3,4,5-TETRAHYDRO-LH-BENZAZEPINE
IT8020557A0 (en) METHOD FOR THE PRODUCTION OF ALUMINUM-SILICATES WITH A ZEOLITE STRUCTURE.
ES2014986B3 (en) METHOD TO MANUFACTURE A SINTERED PRODUCT AT LEAST PARTIALLY.
BG40963A3 (en) Method for preparing 1, 3- disubstituted 2- oxyindols
FI91484B (en) A method for producing a new cell growth regulating factor, oncostatin M.
ES553190A0 (en) A METHOD FOR PREPARING CYCLICAL HEMIAMIDALS AND HEMIAMIDOCETALS, AS WELL AS DIALKYL-ACETALS AND CETALS, OLEPHINICALLY REPLACED IN N.
DE3677812D1 (en) POLYHYDROXYPOLYETHER, METHOD FOR THE PRODUCTION AND USE THEREOF.
ES538579A0 (en) A PROCEDURE FOR THE PRODUCTION OF 3.3 ", 4" -TRI-O-ACILESPIRAMICINA I "-.
DE3576465D1 (en) COLD GAS PRODUCTION METHOD.
KR860004947A (en) Method for producing polyamide-polyurea-containing polymer
DE3682023D1 (en) TRIAZOLYLMETHYL-TERT.-BUTYL-CARBINOL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS PLANT GROWTH REGULATORS.
KR860005812A (en) Method for preparing 4,4-dialkyl-2-azetidinone
DE3780855D1 (en) CELL CULTURE METHOD.
FI853663L (en) FRAMSTAELLNINGSFOERFARANDE FOER 8-HALOGEN-5,6-DIALKOXIKINAZOLINE-2,4-DIONER OCH DERAS SALTER.
ES549472A0 (en) A PROCEDURE FOR PREPARING 1-BETA-D-RIBOFURANOSIL-1,2,4-TRIAZOL-3-CARBOXAMIDE.
ES549095A0 (en) A METHOD FOR PRODUCING BROMODICLOROIMIDAZOLE DERIVATIVES.
EP0219117A3 (en) A method for producing alpha,alpha-dimethyl-delta-valerolactone
DE3672424D1 (en) PRODUCTION METHOD 16-SUBSTITUTED PROSTAGLANDINE-E.
FI840020A (en) FLISSAOL, VARS SAOLLKORG DELATS I TVAO BLOCK.

Legal Events

Date Code Title Description
FG Patent granted

Owner name: ONCOGEN

FG Patent granted

Owner name: METALLEIDO S.R.L.

BB Publication of examined application
FG Patent granted

Owner name: ONCOGEN

MA Patent expired